<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-19T11:22:08+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>首个国产ALK抑制剂！贝达药业「恩沙替尼」获批上市</title>
    <updated>2020-11-19T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/AJCNMtxVygZr4cmmAGH5qA</id>
    <link href="https://mp.weixin.qq.com/s/AJCNMtxVygZr4cmmAGH5qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MSI-H/dMMR晚期实体瘤：各家PD-1/PD-L1表现如何？</title>
    <updated>2020-11-19T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/2oUfBvYFSRa_zS55fm_zOA</id>
    <link href="https://mp.weixin.qq.com/s/2oUfBvYFSRa_zS55fm_zOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：运营专员</title>
    <updated>2020-11-19T09:43:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/R6FS2fxi7NL6OZwrkrIu6w</id>
    <link href="https://mp.weixin.qq.com/s/R6FS2fxi7NL6OZwrkrIu6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>铁打的Biotech，流水的CFO</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/0RDsW2ieZJ6MaI3qsg3Xow</id>
    <link href="https://mp.weixin.qq.com/s/0RDsW2ieZJ6MaI3qsg3Xow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2个月注射1次，HIV暴露前预防效力提高66%！Cabotegravir获突破性疗法资格</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/-NgrD15OSeidzI1PDdE9fw</id>
    <link href="https://mp.weixin.qq.com/s/-NgrD15OSeidzI1PDdE9fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>替雷利珠单抗治疗非小细胞肺癌III期研究中期分析到达OS主要终点</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/lcAFHUMTUJ4vBkDt7XW_3g</id>
    <link href="https://mp.weixin.qq.com/s/lcAFHUMTUJ4vBkDt7XW_3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：医学知识工程师</title>
    <updated>2020-11-18T07:33:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/3XpE4DUyqeWZ47jb1gBZKg</id>
    <link href="https://mp.weixin.qq.com/s/3XpE4DUyqeWZ47jb1gBZKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDK4/6抑制剂角逐早期乳腺癌：阿贝西利为何后来居上？</title>
    <updated>2020-11-17T07:40:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/AZ1QFL_lNZbWXxw1MBv5PQ</id>
    <link href="https://mp.weixin.qq.com/s/AZ1QFL_lNZbWXxw1MBv5PQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>破解PD1耐药黑色素瘤治疗难题！创新IL-12制剂+Keytruda客观缓解率达到30%</title>
    <updated>2020-11-17T07:40:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/P4XXdPPD-9amwOLvNRWBRg</id>
    <link href="https://mp.weixin.qq.com/s/P4XXdPPD-9amwOLvNRWBRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：客户服务经理</title>
    <updated>2020-11-17T07:40:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/uIx5wnk4z0Yd5dd6qKs-zw</id>
    <link href="https://mp.weixin.qq.com/s/uIx5wnk4z0Yd5dd6qKs-zw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品专利攻防战实力排行：恒瑞、天晴、石药位居前三</title>
    <updated>2020-11-16T07:40:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/j97rpx_jXyuNxvChttMknQ</id>
    <link href="https://mp.weixin.qq.com/s/j97rpx_jXyuNxvChttMknQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康朴生物医药在美国启动KPG-818 治疗系统性红斑狼疮Ib/IIa期临床试验</title>
    <updated>2020-11-16T07:40:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/8bg_UVoOKJmoYi-3GwouHQ</id>
    <link href="https://mp.weixin.qq.com/s/8bg_UVoOKJmoYi-3GwouHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药魔方招聘：大客户经理</title>
    <updated>2020-11-16T07:40:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/7nkEMW-iR1PVASOG6-8Fpg</id>
    <link href="https://mp.weixin.qq.com/s/7nkEMW-iR1PVASOG6-8Fpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>携手罕见 希望同行丨海南博鳌乐城维健罕见病临床医学中心揭牌成立</title>
    <updated>2020-11-16T07:40:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/ewaIPhQ6ojjQ_P7jz7gsCA</id>
    <link href="https://mp.weixin.qq.com/s/ewaIPhQ6ojjQ_P7jz7gsCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ALK抑制剂一线PK，哪个更好？</title>
    <updated>2020-11-15T08:11:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/bAYtouiHMEkwjE2vZ5ErNA</id>
    <link href="https://mp.weixin.qq.com/s/bAYtouiHMEkwjE2vZ5ErNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature重要发现：PD-1抗体“新搭档”——PCSK9抑制剂</title>
    <updated>2020-11-15T08:11:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/Q_zabmF7sR3GOzXIiPvd4A</id>
    <link href="https://mp.weixin.qq.com/s/Q_zabmF7sR3GOzXIiPvd4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Biotech沉思录</title>
    <updated>2020-11-14T08:16:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/fQTyDjHlj4n-oblNqKM2gA</id>
    <link href="https://mp.weixin.qq.com/s/fQTyDjHlj4n-oblNqKM2gA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>KRAS抑制剂「图鉴」</title>
    <updated>2020-11-13T07:37:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/uLS_HBycroJDS7nSHpDwUA</id>
    <link href="https://mp.weixin.qq.com/s/uLS_HBycroJDS7nSHpDwUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业战略布局细胞治疗，彰显创新转型决心</title>
    <updated>2020-11-13T07:37:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/29LpuO9zfp0JF-H67rsqIw</id>
    <link href="https://mp.weixin.qq.com/s/29LpuO9zfp0JF-H67rsqIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首款抗破伤风毒素全人源单抗获批在澳洲进入I期临床</title>
    <updated>2020-11-13T07:37:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/jeC_laf48HQusa5yHiCKEA</id>
    <link href="https://mp.weixin.qq.com/s/jeC_laf48HQusa5yHiCKEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>